Galapagos

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galapagos and other ETFs, options, and stocks.

About GLPG

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis.

CEO

Paulus Stoffels

CEOPaulus Stoffels

Employees

1,309

Employees1,309

Headquarters

Mechelen, Brussels Region

HeadquartersMechelen, Brussels Region

Founded

1999

Founded1999

Employees

1,309

Employees1,309

GLPG Key Statistics

Market cap

2.84B

Market cap2.84B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

160.03K

Average volume160.03K

High today

$43.50

High today$43.50

Low today

$41.93

Low today$41.93

Open price

$42.20

Open price$42.20

Volume

241.10K

Volume241.10K

52 Week high

$72.11

52 Week high$72.11

52 Week low

$41.65

52 Week low$41.65

GLPG News

Simply Wall St 5d

Investors three-year losses grow to 67% as the stock sheds €200m this past week - Simply Wall St

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. Long term Galapagos NV ( ) shareholders know...

Analyst ratings

62%

of 13 ratings

Buy

30.8%

Hold

61.5%

Sell

7.7%

GLPG Earnings

-$1.60

-$0.97

-$0.34

$0.29

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Available Nov 3, After Hours

ActualAvailable Nov 3, After Hours